Implantable polymer surfaces exhibiting reduced in vivo inflammatory responses
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jul 23, 2024
Grant Date -
Jul 25, 2019
app pub date -
Jan 23, 2018
filing date -
Jan 23, 2018
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
Embodiments of the invention provide optimized polymeric surfaces adapted for use with implantable medical devices as well as methods for making and using such polymeric surfaces. These polymer surfaces have a constellation of features that function to inhibit or avoid an inflammatory immune response generated by implantable medical devices. Typical embodiments of the invention include an implantable glucose sensor used in the management of diabetes having a polymer surface with the disclosed constellation of features.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully